Trial intelligence / Profile preview

Sayana Press Home Self-Injection Study

NCT03034057Phase 4Completed

Sponsor
Pfizer
Start
Aug 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of dmpa-sc in contraception, sponsored by Pfizer. Primary endpoint: Percentage of Successful Self-Injections Performed of All Attempts at Home on Schedule at 1 year. Started Aug 2017; status: completed.

02

Drugs

dmpa-sc
03

Conditions

contraception

Beyond the preview

Go deeper on NCT03034057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03034057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call